Skip to main content
Signal8

FOXO TECHNOLOGIES INC. (FOXO)

FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.

Sector: Services-Commercial Physical & Biological Research

Industry: Medical - Care Facilities

FOXO Technologies Inc. logo

FOXO Technologies Inc.

OTC:FOXOHealthcare
+0.00%$0.1000
Mkt Cap$166K
Float1.66M
O/S1.66M
Inst Own-
SI0.2%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$16.37M
Net Income-$12.43M
Total Assets$44.58M
Free Cash Flow-$3.93M
Debt & Equity
Debt 50%
Equity 50%
Preferred 0%
Total Debt$10.97M
Total Equity$11.14M
Preferred Stock$10
Shares Outstanding
Short Interest
Split History5 splits · 5 reverse
2-year cumulative
1:179,100Over cap

Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period

  1. 1:3Reverse split
    Jul 1, 20263 shares → 1
  2. 1:3,000Reverse split
    Jul 1, 20263,000 shares → 1
  3. 1:2.0Reverse split
    Jul 28, 20252.0 shares → 1
  4. 1:10Reverse split
    Apr 29, 202510 shares → 1
  5. 1:10Reverse split
    Nov 7, 202310 shares → 1
Balance Sheet Details
Assets$44.58M
Liabilities$33.5M
Accounts Receivable$2.47M
Accounts Payable$6.97M
Inventory$184K
PP&E (Net)$3.87M
Goodwill$27.82M
Intangible Assets$9.77M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$16.37M$4.05M$145K$511K$120K$63K
YoY Growth304.0%2688.6%-71.6%325.8%90.5%-
Cost of Revenue$8.33M$2.48M$132K$344K$0$0
Gross Profit$8.04M$1.57M$13K$167K$120K$63K
Gross Margin49.1%38.7%8.9%32.7%100.0%100.0%
Research and Development$182K$312K$900K$3.05M$4.88M$1.9M
Selling, General, and Administrative$11.36M$7.17M$19.4M$25.83M$10.27M$6.89M
Other$6.83M$1.85M$1.9M$11.46M$0$0
Total Operating Expenses$18.37M$9.33M$22.2M$40.33M$15.15M$8.79M
Operating Income (EBIT)-$10.33M-$7.76M-$22.19M-$40.17M-$15.03M-$8.73M
Operating Margin-63.1%-191.6%-15271.2%-7860.5%-12525.8%-13857.1%
Interest Expense-$3.43M$3.91M$1.06M$1.44M$1.12M$0
Interest Income$0$0$0$0$0$61K
Other Income (Expense)-$2.3M-$4.66M-$4.26M-$55.09M-$23.46M$77K
Income Before Tax (EBT)-$12.63M-$12.42M-$26.45M-$95.25M-$38.49M-$8.65M
Income Tax Expense-$200K$0$0$0$0$0
Net Income-$12.43M-$12.41M-$26.45M-$95.25M-$38.49M-$8.65M
Net Income Margin-75.9%-306.2%-18205.2%-18640.9%-32073.3%-13734.9%
Supplementary Data
EPS-0.13-0.93-7.08-84.00-66.13-43.27
Diluted EPS-0.13-0.93-7.08-84.00-66.13-43.27
Weighted Average OS264.78M13.37M3.74M1.13M582,000200,000
EBITDA-$8.6M-$7.28M-$24.11M-$92.3M-$37.27M-$7.46M
EBITDA Margin-52.5%-179.6%-16592.8%-18062.6%-31060.0%-11849.2%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Assets
Current Assets
Cash and Cash Equivalents$207K$68K$38K$5.51M$6.86M$8.12M
Short-Term Investments$0$0$0$0$0$0
Cash and Short-Term Investments$207K$68K$38K$5.51M$6.86M$8.12M
Accounts Receivable$2.47M$2.27M$100K$100K$0$0
Inventory$184K$161K$0$1.31M$295K$0
Other Current Assets$155K$90K$9K$14K$23K$12K
Total Current Assets$3.11M$2.88M$233K$12.3M$7.62M$8.59M
Long-Term Assets
Property, Plant & Equipment Net$3.87M$4.35B$0$0$187K$167K
Goodwill$27.82M$25.46M$0$0$0$0
Intangible Assets$9.77M$9.02M$378K$2.04M$191K$0
Long-Term Investments$0$0$0$0$100K$419K
Deferred Tax Assets$0$0$0$0$19.46M$0
Other Long-Term Assets$0-$4.34M$114K$21.06M$2.75M$244K
Total Long-Term Assets$41.47M$38.83M$492K$23.1M$22.69M$830K
Other Assets$0$0$0$0$0$0
Total Assets$44.58M$41.71M$725K$35.41M$30.3M$9.42M
Liabilities
Current Liabilities
Accounts Payable$6.97M$6.68M$4.56M$3.47M$3.46M$366K
Short-Term Debt$7.79M$10.22M$4.2M$1.41M$32.2M$0
Current Income Tax Payable$0$5.2M$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0
Other Current Liabilities$2.17M$8.32M$3.88M$1.04M$0$0
Total Current Liabilities$28.66M$32.73M$14.34M$6.91M$36.06M$614K
Long-Term Liabilities
Long-Term Debt$0$0$0$1.73M$0$0
Long-Term Unearned Revenue$0$0$0$0$7.04M$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0
Other Long-Term Liabilities$1.67M$41K$489K$20.06M$12.42M$90K
Total Long-Term Liabilities$4.84M$3.71M$489K$21.79M$19.46M$90K
Other Liabilities$0$0$0$0$0$0
Total Liabilities$33.5M$36.44M$14.82M$28.7M$55.52M$704K
Stockholders' Equity
Preferred Stock$10$3$0$0$21.85M$21.85M
Common Stock$250K$2K$1K$3K$1$0
Retained Earnings-$224.64M-$190.54M-$177.06M-$147.23M-$51.98M-$13.49M
Comprehensive Income & Other$0$0$0$0$0$0
Other Stockholders' Equity$235.54M$195.86M$162.96M$153.94M$26.76M$22.21M
Total Equity$11.14M$5.32M-$14.1M$6.71M-$25.22M$8.72M
Minority Interest-$69K-$52K$0$0$0$0
Total Liabilities and Equity$44.65M$41.76M$725K$35.41M$30.3M$9.42M
Supplementary Data
Total Debt$10.97M$14.25M$4.2M$3.14M$32.2M$0
Net Debt$10.76M$14.19M$4.17M-$2.38M$25.35M-$8.12M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Operating Activities
Net Income-$12.45M-$12.42M-$26.45M-$95.25M-$38.49M-$1.78M
Depreciation & Amortization$597K$1.24M$1.28M$1.51M$98K$1.26M
Deferred Income Tax-$183K$0$0$0$400K$0
Stock-Based Compensation-$164K-$102K$381K$11.04M$131K$0
Changes in Working Capital:
  Accounts Receivable-$119K$554K$18.57M$890K-$1.92M$0
  Inventory-$14K$40K$1.31M-$1.02M-$295K$0
  Accounts Payable$186K$1.16M$1.3M$127K$3.09M$0
  Other Working Capital$176K$1.03M-$13.16M-$3.35M-$305K-$443K
Total Working Capital Change$229K$2.78M$8.02M-$3.35M$572K-$443K
Other Non-Cash Items$8.1M$5.67M$10.13M$62.3M$22.23M$482K
Net Cash from Operating-$3.87M-$2.84M-$6.64M-$23.76M-$15.05M-$481K
Investing Activities
Capital Expenditures-$62K$0$0-$110K-$242K$0
Acquisitions$0$13K$0$0-$63K$0
Purchases of Investments$0$0$0$0$0-$201.25M
Sales of Investments$0$0$0$0$0$0
Other Investing Activities-$594K$0$0-$1.76M-$50K$0
Net Cash from Investing-$656K$13K$0-$1.87M-$355K-$201.25M
Financing Activities
Debt Repaid----$31.46M--
Common Stock Issuance$3.1M$0$1.18M$0$0$203.29M
Common Stock Repurchases$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0
Other Financing Activities$0-$42K-$299K-$6.01M$3.64M$50K
Net Cash from Financing$4.66M$2.86M$1.17M$24.29M$14.14M$203.2M
Forex Effect$0$0$0$0$0-$50K
Net Change in Cash$139K$30K-$5.48M-$1.34M-$1.27M$1.42M
Supplementary Data
Operating Cash Flow-$3.87M-$2.84M-$6.64M-$23.76M-$15.05M-$481K
Capital Expenditure-$62K$4-$3-$1.87M-$242K$5
Free Cash Flow-$3.93M-$2.84M-$6.64M-$25.63M-$15.3M-$481K
Cash at Beginning$68K$38K$5.51M$6.86M$8.12M$0
Cash at End$207K$68K$38K$5.51M$6.86M$1.42M